JRCT ID: jRCT1030240521
Registered date:05/12/2024
PENG & QoR-15: a systematic review and meta-analysis
Basic Information
Recruitment status | Suspended |
---|---|
Health condition(s) or Problem(s) studied | patients who receive hip arthoplasty, including total hip arthroplasty, hemiarthroplasty |
Date of first enrollment | 05/12/2024 |
Target sample size | 1000 |
Countries of recruitment | |
Study type | Other |
Intervention(s) | PENG block |
Outcome(s)
Primary Outcome | QoR-15, QoR-40 score on POD1 (evaluated within 24 hours from surgery, on postoperative day 1, or on the second day of surgery) |
---|---|
Secondary Outcome | (1) QoR-15 score reported in other time frame: 48 hours or on POD2, etc. (2) QoR-40 score reported in any time frame: POD1, POD2, etc. (3) Time to first mobilization: the time from the end of surgery to the first mobilization, ambulation, walk, or getting up from bed (4) First ambulation distance (5) First up-and-go test (6) Quadriceps strength on POD1 (7) Other evaluation tool of recovery or patient-reported outcomes, such as the Hip disability and Osteoarthritis Outcome Score for Joint Replacement (HOOS, JR.), the Patient-Reported Outcomes Measurement Information System (PROMIS) (8) Patient satisfaction: any satisfaction questionnaire results with perioperative pain management techniques or postoperative analgesia evaluated on a certain scale were included (9) Postoperative complications reported if possible |
Key inclusion & exclusion criteria
Age minimum | >= 18age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | Eligible studies included prospectively registered clinical trials in forms of articles on peer-reviewed journals, letters, or conference abstracts, where (1) adult patients who received any types of hip arthroplasty under either general or spinal anesthesia; (2) patients were allocated to PENG block (including ultrasound-guided, X-ray-guided, CT-guided or traditional landmark-based techniques) as an intervention compared with any other kind of analgesia management other than PENG block for perioperative pain management. No language restrictions were applied. Studies published as Non-English, Chinese, Japanese studies were translated using an online translator. |
Exclude criteria | Exclusion criteria include: (1) studies that had another block as a co-intervention, except for lateral femoral cutaneous nerve (LFCN) block or infiltration using local anesthetics; (2) studies of catheter-based continuous blocks; (3) studies where both intervention and comparison were PENG block; (4) studies with data that could not be used for statistical analysis, or studies with incomplete data, or data that could not be extracted after contacting the original authors; and (5) studies that were duplicate publications, or not prospectively registered. |
Related Information
Primary Sponsor | Jin Zhuan |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Zhuan Jin |
Address | 929, Higashi-cho, Kamogawa City, Chiba Prefrecture Chiba Japan 2960041 |
Telephone | +81-4-7092-2211 |
jin.zhuan@kameda.jp | |
Affiliation | Kameda Medical Center |
Scientific contact | |
Name | Zhuan Jin |
Address | 929, Higashi-cho, Kamogawa City, Chiba Prefrecture Chiba Japan 2960041 |
Telephone | +81-4-7092-2211 |
jin.zhuan@kameda.jp | |
Affiliation | Kameda Medical Center |